111 Capital Portfolio holdings
Top Buys
| 1 |
AstraZeneca
AZN
|
+$17.5M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$9.14M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$8.51M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$4.54M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.2M |
Top Sells
Sector Composition
| 1 | Technology | 30.59% |
| 2 | Healthcare | 11.62% |
| 3 | Communication Services | 10.07% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Financials | 7.5% |
Similar funds
111 Capital's Q1 2026 Portfolio in Review
As of Q1 2026, 111 Capital held 479 positions worth $406M, down 11% from $458M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
111 Capital withdrew a net $30.1M in Q1 2026, closing 151 positions and reducing 86 holdings. Its most notable exit was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $33.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, 111 Capital opened a new position in iShares Semiconductor ETF worth $8.2M.
- 111 Capital's largest Q1 2026 buy was iShares Semiconductor ETF: 24,935 shares worth $8.2M.
- 111 Capital added most to AstraZeneca in Q1 2026, an estimated $17.5M increase.
- 111 Capital's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.8M.
- 111 Capital fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q1 2026, selling an estimated $33.5M.
- 111 Capital's ten largest holdings make up 35% of its $406M portfolio in Q1 2026.
- 111 Capital opened 157 new positions and closed 151 in Q1 2026.
- 111 Capital's portfolio value fell 11% quarter-over-quarter to $406M.
Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.